Crossmark

Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2023.04.008

Published Print: 2025-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Santos García, D. https://orcid.org/0000-0002-3126-5111
Pagonabarraga Mora, J.

Escamilla Sevilla, F.

García Ruiz, P.J.

Infante Ceberio, J.

Kulisevsky Bojarski, J.

Linazasoro Cristóbal, G.

Luquín Piudo, M.R.

Martínez Castrillo, J.C.

Jesús Maestre, S.

Vela Desojo, L. https://orcid.org/0000-0001-6663-395X
Campos Lucas, F.J. https://orcid.org/0000-0002-2517-3384
Caballero Martínez, F. https://orcid.org/0000-0001-7873-2824
Mir, P.
License Information

Text and Data Mining valid from 2025-03-01

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2023-06-29
More Information

This article is maintained by: Elsevier

Article Title: Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2023.04.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2023.04.002

Content Type: article

Copyright: © 2023 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.